Reversal of the Multidrug-Resistant Phenotype of Chinese Hamster Ovary Cells by L-Histidinol
Authors:
- 22 May 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 81 (10) , 798-803
Abstract
The amino acid analogue L-histidinol reverses the multidrug-resistance (MDR) attribute of the colchicine-resistant (CHR) variant CHRC5, a Chinese hamster ovary cell line that overexpresses a plasma membrane-associated glyco-protein and is resistant to colchicine (CH), daunorubicin, and vinblastine sulfate (VS). The level of cell kill achieved in CHRC5 cells by combinations of L-histidinol and either daunorubicin or CH approached that achieved in AUXB1 parent cells by these two drugs, whereas L-histodinol-VS combinations killed even more CHRC5 cells than VS in the parental line. The capacity of L-histidinol to reverse the MDR phenotype of the CHRC5 line was time and dose dependent and was eliminated by the addition of a twofold molar excess of L-histidine. The reversal of the MDR trait by L-histidinol appears to be independent of the drug uptake mechanism.Keywords
This publication has 9 references indexed in Scilit:
- EFFECT OF L-HISTIDINOL ON THE METABOLISM OF 5-FLUOROURACIL IN THE BALB/C X DBA/8 F1 MURINE TUMOR SYSTEM1988
- SPECIFICITY, SCHEDULE, AND PROLIFERATION DEPENDENCE OF INFUSED L-HISTIDINOL AFTER 5-FLUOROURACIL IN MICE1988
- Effects of L-Histidinol on the Susceptibility of P815 Mastocytoma Cells to Selected Anticancer Drugs In Vitro and in DBA/2J Mice2JNCI: Journal of the National Cancer Institute, 1987
- Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine.Proceedings of the National Academy of Sciences, 1987
- FAILURE OF L-HISTIDINOL TO IMPROVE THE THERAPEUTIC EFFICIENCY OF 5-FLUOROURACIL AGAINST MURINE BREAST-TUMORS1987
- Histidinol-Mediated Enhancement of the Specificity of Two Anticancer Drugs in Mice Bearing Leukemic Bone Marrow Disease2JNCI: Journal of the National Cancer Institute, 1985
- HISTIDINOL-MEDIATED IMPROVEMENT IN THE SPECIFICITY OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE AND 5-FLUOROURACIL IN L1210-LEUKEMIA-BEARING MICE1984
- INCREASED ACCUMULATION OF VINCRISTINE AND ADRIAMYCIN IN DRUG-RESISTANT P388-TUMOR CELLS FOLLOWING INCUBATION WITH CALCIUM-ANTAGONISTS AND CALMODULIN INHIBITORS1982
- LASER FLOW CYTOMETRIC STUDIES ON THE INTRACELLULAR FLUORESCENCE OF ANTHRACYCLINES1980